RIVAROXABAN vasc Spirig HC cpr pell 2.5 mg 56 pce

7680685510013 CH-68551 B01AF01 06.03.0.

Reimbursement limitations:

RIVA.vas.Spi

En association avec de l’acide acétylsalicylique (AAS), pour la prévention secondaire (après événement) des événements …

RIVAROXABAN vasc Spirig HC cpr pell 2.5 mg 56 pce
RIVAROXABAN vasc Spirig HC cpr pell 2.5 mg 56 pce
RIVAROXABAN vasc Spirig HC cpr pell 2.5 mg 56 pce
1 / 3
google

Details

Product number
6855101
CPT
-
Packaging group
56
Unit
Tablette(n)
Composition
rivaroxabanum 2.5 mg, cellulosum microcristallinum, lactosum monohydricum 58.03 mg, povidonum K 30, amylum pregelificatum, crospovidonum, natrii laurilsulfas, magnesii stearas, Überzug: hypromellosum, E 171, macrogolum 4000, E 172 (flavum), pro compresso obducto corresp. natrium 0.053 mg.

Articles (1)

Rivaroxaban vascular Spirig HC 2.5 mg, Filmtabletten
Filmtabletten
56
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
23/08/2024
Professional SmPC
Français
23/08/2024
Professional SmPC
Italien
23/08/2024
Patient information leaflet
Allemand
21/08/2024
Patient information leaflet
Français
21/08/2024
Patient information leaflet
Italien
21/08/2024

Detailed composition

Substance Quantity Type Category
(N/A)
2.5 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
58.03 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FTODK
(N/A)
0.053 MG Substance HBESI

Reimbursement information

Public price
CHF 45.60
Specialties list
Yes
Generic
Yes

Reimbursement limitation

SL addition date: 01/08/2024

Authorization holder

Spirig HealthCare AG

4622 Egerkingen

Authorization information

Swissmedic authorization number
68551
Drug name
Rivaroxaban vascular Spirig HC, Filmtabletten
Galenic form
FILM
ATC Code
B01AF01
Authorization status
Z
Dispensation category
B
First authorization
16/03/2023
Authorization expiration date
15/03/2028
IT number
06.03.0.
Domain
Human medicine
Field of application
In Kombination mit Acetylsalicylsäure zur Prävention schwerwiegender atherothrombotischer Ereignisse bei Patienten mit koronarer Herzkrankheit oder manifester peripherer arterieller Gefässerkrankung und einem hohen Risiko für ischämische Ereignisse

Packaging details

Description (FR)
RIVAROXABAN vasc Spirig HC cpr pell 2.5 mg 56 pce
Description (DE)
RIVAROXABAN vasc Spirig HC Filmtabl 2.5 mg 56 Stk
Market launch
16/03/2023
Narcotic (BTM)
No

Original drug

Xarelto, Filmtabletten
CHF 17.25
View original

Other packaging sizes

RIVAROXABAN vasc Spirig HC cpr pell 2.5 mg 196 pce
196 TABL
View